Effects of Silymarin on Hepatitis C Virus and Heme Oxygenase-1 Gene Expression in Human Liver Cells
Background: Hepatitis C virus (HCV) infection is a global medical problem. The current standard of care for chronic hepatitis C (CHC) is pegylated interferon plus ribavirin therapy, but this treatment is expensive, has significant side effects and, at best, is only 50% effective. Silymarin, the main...
| Main Author: | |
|---|---|
| Other Authors: | |
| Format: | Others |
| Language: | en |
| Published: |
Universidad de las Américas Puebla
2007
|
| Subjects: | |
| Online Access: | http://catarina.udlap.mx/u_dl_a/tales/documentos/mbt/bonifaz_p_ve/ |